Floatz logo

Cyclophosphamide

Microsatellite Instability High

NextCure, Inc.Small moleculePhase 1/2Active
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
89/ 100

Competitive context

10 Active assets in the Microsatellite Instability High cohort.

Asset / SponsorPhaseRating
Pyrotinib
Sun Yat-sen University
Phase 3B
Tislelizumab
Sun Yat-sen University
Phase 3B
rc48-adc
Sun Yat-sen University
Phase 3B
Toripalimab
Sun Yat-sen University
Phase 2CCC
Dfn-15
Sun Yat-sen University
Phase 2CCC

View all 12 →

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →